the investment unit value and price as specified in the scheme; (2.2) Calculate the NAV and investment unit values using a fair price. The value per investment unit shall be rounded up to a minimum of
shares as consideration method Number of shares issued as consideration x 100 Number of issued and paid-up shares of the Company N/A3 The highest transaction size 14.84% Remark: 1 Unable to calculate this
adjustment specified in the terms and conditions thereof. Currently, the company 2 is not able to calculate the adjustment ratio of Warrants ECF-W3, since in calculating the price and ratio of new exercise of
. Currently, the company 2 is not able to calculate the adjustment ratio of Warrants ECF-W3, since in calculating the price and ratio of new exercise of rights, it shall be calculated from “the market price of
for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be transferred on share sale and purchase date from the seller’s connected
established in 2011 and operated business Original Equipment Manufacturer or OEM for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be
skin medicine under trademarks including trademark of “DERMALIS”, (which will be Criterion Calculation Method Transaction size 1. Net tangible assets (NTA) Proportion of assets acquired (100%) x NTA AT
5.8 Manufacture and skincare products, cosmetics, food supplements and medicine used to treat skin diseases segment 9,708 2.2 13,124 3.2 (3,416) (26.0) total 443,248 100.0 417,617 100.0 25,631 6.1 The
32.6 Debt Service Coverage 904.1 4.4 103.9 4.6 Total Debt to Equity 0.2 0.4 0.2 0.4 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of medicine
operations for 2nd Quarter of 2017 decreased to 71.69%, while it was 74.38% for the 2nd Quarter of 2016. These resulted from the efficiency of medicine and medical supplies cost management, introducing an